close

Indiana Ophthalmics faces CDSCO probe; Pharmexcil may suspend membership

CDSCO starts probe based in complaint by Sri Lanka that eyedrops made by the firm are linked to eye infections in more than 30 people

Sohini Das Mumbai
Indiana Opthalmics
Premium

Indiana Opthalmics, Pic credit: Facebookce

Listen to This Article

Trouble for Indian drug exporters continues with the Central Drugs Standard Control Organisation (CDSCO) investigating a complaint raised by Sri Lanka that eye drops made by a Gujarat-based firm are linked to eye infections in more than 30 people in the neighbouring country. Moreover, Indiana Ophthalmics, the Gujarat-based manufacturer, has now received a show-cause notice from the Pharmaceutical Exports Promotion Council (Pharmexcil). Its membership may be cancelled if it fails to respond by Saturday.
Indiana Ophthalmics is registered with the National Medicines Regulatory Authority of Sri Lanka and has been supplying prednisolone eye drops that are used to treat inflammation of the eyes caused by certain conditions for several years now. A source said the samples from the company have been sent for testing by CDSCO officials and it may take up to 10-15 days to get the reports on sterility etc.
In April Sri Lanka’s health
Or

Also Read

Syrup deaths in Uzbekistan: Pharmexcil suspends Marion Biotech's membership

Chennai-based firm's eye drops contaminated, says US FDA report

Regulators halt eye products' production at Global Pharma Healthcare site

Pricing regulator sets mechanism to fix prices of off-patent drugs

Imported drugs for rare diseases to be exempt from customs duty

Sterlite Copper gets access to Thoothukudi unit for maintenance after 5 yrs

IndiGo widens global footprint with 6 new destinations, to add 174 flights

AI sends out questionnaires to assess customer satisfaction levels: CEO

BIS notifies 31 Indian standards related to Ayush herbs and products

DCB Bank forms committee, begins search for successor to CEO Natarajan

First Published: Jun 02 2023 | 7:56 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com